Motor Neuron Disease Multiple sclerosis (MS) is an autoimmune condition in which the immune system attacks the central nervous system (CNS), leading to demyelination. It may cause numerous physical and mental symptoms, and often progresses to physical and cognitive disability. Disease onset usually occurs in young adults, and is more common in women.

MS affects the areas of the brain and spinal cord known as the white matter. Specifically, MS destroys oligodendrocytes, which are the cells responsible for creating and maintaining the myelin sheath, which helps the neurons carry electrical signals. MS results in a thinning or complete loss of myelin and, less frequently, transection of axons.

Type of MS:

Relapsing remitting MS (RRMS):

Periods of acute attacks with worsening of symptoms followed by complete or partial recovery (remission)

Secondary progressive MS (SPMS):

Following an initial period of relapsing remitting MS, many people develop secondary progressive MS. This is characterised by a gradual accumulation of disability, either with or without relapses (relapsing SPMS or non-relapsing SPMS).

Primary progressive MS (PPMS):

A gradual accumulation of disability from the beginning, with no distinct periods of relapse and remission.

Progressive-Relapsing MS:

In this relatively rare course of MS (5%), people experience steadily worsening disease from the beginning, but with clear attacks of worsening neurologic function along the way.

StemCell Therapy for Multiple Sclerosis Multiple sclerosis (MS) is widely believed to be an autoimmune condition – the body’s immune system mistakenly attacks, and subsequently damages, the ‘myelin sheath’ protecting nerve cells in the brain and spinal cord. This damage causes messages to and from the brain to be slowed, distorted or stopped altogether. This is what leads to the symptoms of MS.

This stem cell treatment is designed to target the myelin sheath by introducing adult mesenchymal stem cells past the blood brain barrier so they may differentiate into and repair the myelin sheath nerve cells. This process is called remyelination. Further, being that Multiple Sclerosis is an auto-immune condition, mesenchymal stem cells have the ability to rebalance the immune system; keeping it from attacking itself. This process is referred to as immunomodulation. Through remyelination and immunomodulation, we hope to work toward improving the quality of lives of patients dealing with Multiple Sclerosis.

Contact Us For a Free Consultation contact@stemcells21.com | +6626507709

IntelliHealth+ Medical Centre is our treatment facility in Bangkok, Thailand.

www.stemcells21.com | www.IHSurgery.com